Serum methylation levels of TAC1. SEPT9 and EYA4 as diagnostic markers for early colorectal cancers: a pilot study

References

• Ahlquist T, Ling GE, Costa VL, et al. (2008). Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset makers. Mol Cancer 7:94 . doi: 10.1186/1476-4598-7-94
   PubMedGoogle Scholar
• Clark SW, Fee BE, Cleveland JL. (2002). Misexpression of the eyes absent family triggers the apoptotic program. J Biol Chem 277:3560–7
   PubMedGoogle Scholar
• deVos T, Tetzner R, Model F, et al. (2009). Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin Chem 55:1337–46
   PubMed Web of Science ®Google Scholar
• Ebert MP, Model F, Mooney S, et al. (2006). Aristalesss-like-homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. Gastroenterology 131:1418–30
   PubMed Web of Science ®Google Scholar
• Etzioni R, Urban N, Ramsey S, et al. (2003). The case for early detection. Nat Rev Cancer 3:243–52
   PubMed Web of Science ®Google Scholar
• Fong SL, Zhang JT, Lim CK, Eu KW, Liu Y. (2009). Comparison of 7 methods for extracting cell-free DNA from serum samples of colorectal cancer patients. Clin Chem 55:587–9
   PubMed Web of Science ®Google Scholar
• Grützmann R, Molnar B, Pilarsky C, et al. (2008). Sensitive detection of colorectal cancer in peripheral blood by SEPT9 methylation assay. PLoS One 3:e3759 doi: 10.1371/journal.pone.0003759.
   PubMed Web of Science ®Google Scholar
• Herbst A, Rahmig K, Stieber P, et al. (2011). Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer. Am J Gastroenterol 106:1110–18
   PubMed Web of Science ®Google Scholar
• Imperiale TF, Ransohoff DF, Itzkowitz SH, et al. (2004). Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. N Eng J Med 351:2704–14
   PubMed Web of Science ®Google Scholar
• Jahr S, Hentze H, Englisch S, et al. (2001). DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61:1659–65
   PubMed Web of Science ®Google Scholar
• Lee BB, Lee EJ, Jung EH, et al. (2009). Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer. Clin Cancer Res 15:6185--91
   PubMed Web of Science ®Google Scholar
• Lee S, Hwang KS, Lee HJ, et al. (2004). Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia. Lab Invest 84:884–93
   PubMed Web of Science ®Google Scholar
• Lee TH, Montalvo L, Chrebtow V, Busch MP. (2001). Quantitation of genomic DNA in plasma and serum samples, higher concentrations of genomic DNA found in serum than in plasma. Transfusion 41:276–82
   PubMed Web of Science ®Google Scholar
• Leung WK, To KF, Man EP, et al. (2005). Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am J Gastroenterol 100:2274–9
   PubMed Web of Science ®Google Scholar
• Levin B, Lieberman DA, McFarland B, et al. (2008). Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal cancer, and the American College of Radiology. CA Cancer J Clin 58:130–60
   PubMed Web of Science ®Google Scholar
• Li M, Chen WD, Papadopoulos N, et al. (2009). Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 27:858–63
   PubMed Web of Science ®Google Scholar
• Lind GE, Kleivi K, Meling GI, et al. (2006). ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell Oncol 28:259–72
   PubMed Web of Science ®Google Scholar
• Liu Y, Hong Y, Zhao Y, et al. (2008). Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines. Cancer Invest 26:575–82
   PubMed Web of Science ®Google Scholar
• Lofton-Day C, Model F, DeVos T, et al. (2008). DNA methylation biomarkers for blood-based colorectal cancer screening. Clin Chem 54:414–23
   PubMed Web of Science ®Google Scholar
• Lui YY, Chik KW, Chiu RW, et al. (2002). Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48:421–7
   PubMed Web of Science ®Google Scholar
• Luo YX, Chen DK, Song SX, et al. (2011). Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-anlaysis. Int J Clin Pract 65:1313–20
   PubMed Web of Science ®Google Scholar
• Macdonald JS. (1999). Carcinoembryonic antigen screening: Pros and cons. Semin Oncol 26:556–60
   PubMed Web of Science ®Google Scholar
• Mori Y, Cai K, Cheng Y, et al. (2006). A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer. Gastroenterology 131:797–808
   PubMed Web of Science ®Google Scholar
• Morikawa T, Kato J, Yamaji Y, et al. (2005). A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 129:422–48
   PubMed Web of Science ®Google Scholar
• Nakayama H, Hibi K, Taguchi M, et al. (2002). Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. Cancer Lett 188:115–19
   PubMed Web of Science ®Google Scholar
• Rameshwar P, Gascon P. (1996). Induction of negative hematopoietic regulators by neurokinin-A in bone marrow stroma. Blood 88:98–106
   PubMed Web of Science ®Google Scholar
• Rashid A, Shen L, Morris JS, et al. (2001). CpG island methylation in colorectal adenomas. Am J Pathol 159:1129–35
   PubMed Web of Science ®Google Scholar
• Shen L, Kondo Y, Rosner GL, et al. (2005). MGMT promoter methylation and field effect in sporadic colorectal cancer. J Natl Cancer Inst 97:1330–38
   PubMedGoogle Scholar
• Smith RA, Cokkinides V, Eyre HJ. (2006). American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin 56:11–25
   PubMed Web of Science ®Google Scholar
• Summers T, Langan RC, Nissan A, et al. (2013). Serum-based DNA methylation biomarkers in colorectal cancer: potential for screening and early detection. J Cancer 4:210–16
   PubMed Web of Science ®Google Scholar
• Warren JD, Xiong W, Bunker AM, et al. (2011). Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer. BMC Med 9:133 . doi: 10.1186/1741-7015-9-133
   PubMed Web of Science ®Google Scholar
• Woolf SH. (2004). A smarter strategy? Reflections on DNA screening for colorectal cancer. N Engl J Med 351:2755–8
   Google Scholar
• Zou HZ, Yu BM, Wang ZW, et al. (2002). Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res 8:188–91
   PubMed Web of Science ®Google Scholar